SPYH:XETRA:XETRA-SPDR® MSCI Europe Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 238.35

Change

+1.65 (+0.70)%

Market Cap

USD 0.66B

Volume

104.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

ETFs Containing SPYH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.46% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.46% 89% A- 86% B+
Trailing 12 Months  
Capital Gain 19.37% 76% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.37% 76% C+ 75% C
Trailing 5 Years  
Capital Gain 68.92% 79% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.92% 78% C+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 8.28% 67% D+ 65% D
Dividend Return 8.28% 66% D+ 63% D
Total Return N/A 71% C- 68% D+
Risk Return Profile  
Volatility (Standard Deviation) 8.15% 66% D+ 73% C
Risk Adjusted Return 101.60% 97% N/A 97% N/A
Market Capitalization 0.66B 71% C- 62% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike